SNTI
Senti Biosciences·NASDAQ
--
--(--)
--
--(--)
SNTI fundamentals
During Q4 2025, Senti Biosciences (SNTI) reported revenue of 22.00K, a YoY change of 0.00%. Net income was -14.47M, a YoY change of -2271.64%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Mar 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 793.00K -- | 1.10M -- | 793.00K -- | 1.10M -- | 1.36M +71.25% | 1.77M +60.11% | 59.00K -92.56% | 1.29M +16.49% | 937.00K -31.00% | 338.00K -80.86% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 22.00K -- | -- -- |
Sales and Services Revenue | -- -- | 793.00K -- | 1.10M -- | 793.00K -- | 1.10M -- | 1.36M +71.25% | 1.77M +60.11% | 59.00K -92.56% | 1.29M +16.49% | 937.00K -31.00% | 338.00K -80.86% | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 22.00K -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -- -- | 793.00K -- | 1.10M -- | -1.97M -- | 1.10M -- | 1.36M +71.25% | 1.77M +60.11% | -4.23M -114.79% | 1.29M +16.49% | 937.00K -31.00% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 1.18K -- | 9.79M -- | 12.53M -- | 11.68M -- | 12.86M +1091750.59% | 23.13M +136.28% | 16.51M +31.84% | 16.85M +44.31% | 16.25M +26.34% | 16.13M -30.28% | 44.21M +167.74% | 18.70M +10.95% | 16.30M +0.31% | 13.36M -17.17% | 15.21M -65.59% | 16.17M -13.54% | 16.40M +0.59% | 16.80M +25.77% | 16.95M +11.39% | 18.66M +15.41% | 68.80M -- |
Selling, General and Administrative Expenses | -- -- | 4.55M -- | 7.12M -- | 5.27M -- | 5.26M -- | 13.88M +204.83% | 9.99M +40.46% | 9.82M +86.30% | 9.19M +74.77% | 9.25M -33.37% | 9.43M -5.64% | 9.30M -5.21% | 7.52M -18.16% | 4.21M -54.54% | 6.56M -30.44% | 8.08M -13.14% | 7.12M -5.40% | 6.77M +60.98% | 6.43M -1.95% | 5.85M -27.67% | 26.16M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 21.25M -- | -- -- | -- -- | -- -- | 38.23M +79.88% | -- -- | -- -- | 9.43M -- | 9.30M -75.66% | 7.52M -- | 4.21M -- | 6.56M -30.44% | 8.08M -13.14% | 7.12M -5.40% | 6.77M +60.98% | 6.43M -1.95% | 5.85M -27.67% | 26.16M -- |
Research and Development Expenses | -- -- | 5.24M -- | 5.41M -- | 6.41M -- | 7.60M -- | 9.25M +76.64% | 6.52M +20.50% | 7.04M +9.80% | 7.06M -7.16% | 6.88M -25.64% | 9.09M +39.47% | 9.12M +29.63% | 8.78M +24.37% | 9.15M +33.09% | 8.65M -4.81% | 7.77M -14.80% | 9.28M +5.72% | 10.03M +9.59% | 10.52M +21.50% | 7.76M -0.15% | 37.59M -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 25.69M -- | 271.00K -- | -- -- | -- -- | -- -- | 313.00K +15.50% | -- -- | -- -- | -- -- | 5.05M +1514.06% | -- -- |
Other Operating Expenses | 1.18K -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -1.18K -- | -9.00M -- | -11.42M -- | -10.88M -- | -11.76M -998032.43% | -21.77M -142.01% | -14.75M -29.11% | -16.79M -54.29% | -14.96M -27.27% | -15.19M +30.24% | -43.88M -197.50% | -18.70M -11.34% | -16.30M -8.93% | -13.36M +12.06% | -15.21M +65.32% | -16.17M +13.54% | -16.40M -0.59% | -16.80M -25.77% | -16.95M -11.39% | -18.64M -15.27% | -68.78M -- |
Non-Operating Income (Loss) | -- -- | -3.01M -- | 17.00K -- | -19.00K -- | -50.00K -- | 10.22M +439.39% | 445.00K +2517.65% | 1.81M +9605.26% | 1.11M +2324.00% | 938.00K -90.82% | 7.26M +1531.69% | 10.00K -99.45% | 4.19M +276.80% | 2.15M +129.53% | -13.65M -288.00% | 15.56M +155470.00% | 2.29M -45.47% | 2.06M -4.09% | -1.18M +91.37% | 4.17M -73.20% | 7.34M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 9.46M -- | -- -- | -- -- | 5.79M -- | -1.83M -119.37% | 2.40M -- | 324.00K -- | -15.45M -366.65% | 13.42M +832.35% | 0 -100.00% | 0 -100.00% | 0 +100.00% | 0 -100.00% | -- -- |
Other Non-Operating Income (Loss) | -- -- | -3.01M -- | 12.00K -- | -23.00K -- | -54.00K -- | 10.19M +438.27% | -97.00K -908.33% | -8.78M -38086.96% | 51.00K +194.44% | 144.00K -98.59% | 885.00K +1012.37% | 1.42M +116.13% | 1.46M +2764.71% | 1.59M +1006.25% | 1.65M +85.99% | 1.90M +34.30% | 1.89M +29.43% | 1.79M +12.68% | -1.34M -181.65% | 4.07M +113.98% | 6.41M -- |
Net Interest Expense | -- -- | -2.00K -- | -5.00K -- | -4.00K -- | -4.00K -- | -27.00K -1250.00% | -542.00K -10740.00% | -1.13M -28100.00% | -1.06M -26425.00% | -794.00K -2840.74% | -583.00K -7.56% | -426.00K +62.23% | -331.00K +68.80% | -236.00K +70.28% | -150.00K +74.27% | -230.00K +46.01% | -394.00K -19.03% | -270.00K -14.41% | -166.00K -10.67% | -97.00K +57.83% | -927.00K -- |
Interest Income | -- -- | 2.00K -- | 5.00K -- | -7.00K -- | 4.00K -- | 27.00K +1250.00% | 542.00K +10740.00% | -573.00K -8085.71% | 1.06M +26425.00% | 794.00K +2840.74% | -- -- | -- -- | 331.00K -68.80% | 236.00K -70.28% | 150.00K -- | -718.00K -- | 394.00K +19.03% | 270.00K +14.41% | 166.00K +10.67% | -830.00K -15.60% | -- -- |
Pretax Income From Continuing Operations | -1.18K -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -1002276.91% | -11.55M +3.79% | -14.30M -25.40% | -14.99M -37.45% | -13.85M -17.31% | -14.25M -23.36% | -36.62M -156.00% | -18.69M -24.69% | -12.11M +12.57% | -11.20M +21.38% | -28.87M +21.16% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Income Tax Expense | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Income from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -2.34M -- | -3.22M -- | -4.87M -- | -4.45M -- | 21.69M +1028.20% | -28.00K +99.13% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -1.18K -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -1002276.91% | -11.55M +3.79% | -16.64M -45.89% | -18.21M -67.00% | -18.72M -58.55% | -18.70M -61.85% | -14.92M +10.32% | -18.72M -2.78% | -12.11M +35.31% | -11.20M +40.08% | -28.87M -93.43% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Net Income Attributable to Owners of the Company | -1.18K -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -1002276.91% | -11.55M +3.79% | -16.64M -45.89% | -18.21M -67.00% | -18.72M -58.55% | -18.70M -61.85% | -14.92M +10.32% | -18.72M -2.78% | -12.11M +35.31% | -11.20M +40.08% | -28.87M -93.43% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Net Income Attributable to Common Stockholders | -1.18K -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -1002276.91% | -11.55M +3.79% | -16.64M -45.89% | -18.21M -67.00% | -18.72M -58.55% | -18.70M -61.85% | -14.92M +10.32% | -18.72M -2.78% | -12.11M +35.31% | -11.20M +40.08% | -28.87M -93.43% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 1.00K -- | 2.00K -- | -3.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -- | -11.55M +3.79% | -16.64M -45.89% | -18.21M -66.99% | -18.72M -58.54% | -18.70M -61.88% | -14.92M +10.32% | -18.72M -2.78% | -12.11M +35.30% | -11.20M +40.09% | -28.87M -93.43% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -12.01M -- | -11.41M -- | -10.90M -- | -11.81M -- | -11.55M +3.79% | -16.64M -45.89% | -18.21M -66.99% | -18.72M -58.54% | -18.70M -61.88% | -14.92M +10.32% | -18.72M -2.78% | -12.11M +35.30% | -11.20M +40.09% | -28.87M -93.43% | -610.00K +96.74% | -14.11M -16.52% | -14.73M -31.51% | -18.13M +37.21% | -14.47M -2271.64% | -61.44M -- |
Basic EPS | 0 -- | -4.13 -- | -3.9 -- | -0.37 -- | -3.72 -- | -0.86 +79.18% | -0.38 +90.26% | -0.41 -10.81% | -0.42 +88.71% | -4.22 -390.70% | -3.36 -784.21% | -0.41 -- | -2.65 -530.95% | -2.45 +41.94% | -6.31 -87.80% | -0.13 +68.29% | -1.41 +46.79% | -0.56 +77.14% | -0.69 +89.06% | -0.47 -261.54% | -3.13 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -8.24 -- | -- -- | -2.65 -- | -2.45 -- | -6.31 +23.42% | -- -- | -1.41 +46.79% | -0.56 +77.14% | -0.69 +89.06% | -- -- | -- -- |
Basic EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.88 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | 0 -- | -4.13 -- | -3.9 -- | -- -- | -3.72 -- | -0.86 +79.18% | -0.38 +90.26% | -- -- | -0.42 +88.71% | -4.22 -390.70% | -3.36 -784.21% | -- -- | -2.65 -530.95% | -2.45 +41.94% | -6.31 -87.80% | -- -- | -1.41 +46.79% | -0.56 +77.14% | -0.69 +89.06% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -8.24 -- | -- -- | -2.65 -- | -2.45 -- | -6.31 +23.42% | -- -- | -1.41 +46.79% | -0.56 +77.14% | -0.69 +89.06% | -- -- | -- -- |
Diluted EPS from Discontinued Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.88 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What is Senti Biosciences's latest dividend and current dividend yield?What is Senti Biosciences's gross profit margin?What guidance did Senti Biosciences's management provide for the next earnings period?What does Senti Biosciences do and what are its main business segments?What is the market's earnings forecast for Senti Biosciences next quarter?What factors drove the changes in Senti Biosciences's revenue and profit?Did Senti Biosciences beat or miss consensus estimates last quarter?What were the key takeaways from Senti Biosciences's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
